IL9 and cancer: As reported above, cancer cells modulate the expression and secretion of several anti-proliferative molecules on DBMSCs (Table 1), including, CD40LG, CXCL9, IL9R, IL-15, TNFSF13B, IL-9, IL-17, and CXCL1 [35,36,38,47,52,53,101].